New Drug Helps Patients With Atrial Fibrillation
The experimental anti-clotting drug apixaban beat aspirin at preventing dangerous clots or strokes in people with the abnormal heart rhythm atrial fibrillation, according to final results of the so-called AVERROES trial.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.